中国医学前沿杂志(电子版)
中國醫學前沿雜誌(電子版)
중국의학전연잡지(전자판)
Chinese Journal of the Frontiers of Medical Science (Electronic Version)
2015年
9期
17-22
,共6页
陈丽%李晓青%种莉%刘鹏%侯辰%张李娜%李锐
陳麗%李曉青%種莉%劉鵬%侯辰%張李娜%李銳
진려%리효청%충리%류붕%후신%장리나%리예
二甲双胍%高血糖状态%小胶质细胞%炎性介质
二甲雙胍%高血糖狀態%小膠質細胞%炎性介質
이갑쌍고%고혈당상태%소효질세포%염성개질
Metformin%Hyperglycemia%Microglia%Proinlfammatory cytokine
目的:探讨二甲双胍对缺氧状态下高血糖诱导小胶质细胞释放炎性因子的调节作用。方法将体外培养的N9小胶质细胞分为四组:正常血糖组、正常血糖+二甲双胍组、高血糖组、高血糖+二甲双胍组。正常血糖+二甲双胍组与高血糖+二甲双胍组细胞均加入2 mmol/L二甲双胍处理12小时,四组细胞均进行缺氧处理24小时(3% O2)。采用小干扰RNA(siRNA)靶向沉默腺苷酸活化蛋白激酶α1(AMPKα1),采用实时定量聚合酶链式反应(qRT-PCR)和蛋白质印迹法检测AMPKα1的mRNA和蛋白水平,并采用酶联免疫吸附测定(ELISA)检测各组细胞白细胞介素(IL)-6、IL-1β、肿瘤坏死因子-α(TNF-α)分泌水平。结果二甲双胍对缺氧状态下高血糖诱导的炎性因子(IL-6、IL-1β、TNF-α)蛋白分泌具有抑制作用,并随着浓度的增加,抑制作用增强。高血糖组IL-6、IL-1β、TNF-α mRNA及蛋白分泌水平高于正常血糖组(P<0.05);高血糖+二甲双胍组IL-6、IL-1β、TNF-α蛋白分泌水平低于高血糖组(P<0.05);正常血糖组与正常血糖+二甲双胍组IL-6、IL-1β、TNF-α蛋白分泌水平比较差异无显著性(P>0.05)。而沉默AMPKα1能够上调高血糖+二甲双胍状态下IL-6、IL-1β、TNF-α蛋白分泌水平,与仅转染si-control细胞比较差异具有显著性(P<0.05)。结论二甲双胍能够抑制缺氧状态下高血糖诱导小胶质细胞炎性因子的释放,而AMPKα1在其中发挥关键作用。
目的:探討二甲雙胍對缺氧狀態下高血糖誘導小膠質細胞釋放炎性因子的調節作用。方法將體外培養的N9小膠質細胞分為四組:正常血糖組、正常血糖+二甲雙胍組、高血糖組、高血糖+二甲雙胍組。正常血糖+二甲雙胍組與高血糖+二甲雙胍組細胞均加入2 mmol/L二甲雙胍處理12小時,四組細胞均進行缺氧處理24小時(3% O2)。採用小榦擾RNA(siRNA)靶嚮沉默腺苷痠活化蛋白激酶α1(AMPKα1),採用實時定量聚閤酶鏈式反應(qRT-PCR)和蛋白質印跡法檢測AMPKα1的mRNA和蛋白水平,併採用酶聯免疫吸附測定(ELISA)檢測各組細胞白細胞介素(IL)-6、IL-1β、腫瘤壞死因子-α(TNF-α)分泌水平。結果二甲雙胍對缺氧狀態下高血糖誘導的炎性因子(IL-6、IL-1β、TNF-α)蛋白分泌具有抑製作用,併隨著濃度的增加,抑製作用增彊。高血糖組IL-6、IL-1β、TNF-α mRNA及蛋白分泌水平高于正常血糖組(P<0.05);高血糖+二甲雙胍組IL-6、IL-1β、TNF-α蛋白分泌水平低于高血糖組(P<0.05);正常血糖組與正常血糖+二甲雙胍組IL-6、IL-1β、TNF-α蛋白分泌水平比較差異無顯著性(P>0.05)。而沉默AMPKα1能夠上調高血糖+二甲雙胍狀態下IL-6、IL-1β、TNF-α蛋白分泌水平,與僅轉染si-control細胞比較差異具有顯著性(P<0.05)。結論二甲雙胍能夠抑製缺氧狀態下高血糖誘導小膠質細胞炎性因子的釋放,而AMPKα1在其中髮揮關鍵作用。
목적:탐토이갑쌍고대결양상태하고혈당유도소효질세포석방염성인자적조절작용。방법장체외배양적N9소효질세포분위사조:정상혈당조、정상혈당+이갑쌍고조、고혈당조、고혈당+이갑쌍고조。정상혈당+이갑쌍고조여고혈당+이갑쌍고조세포균가입2 mmol/L이갑쌍고처리12소시,사조세포균진행결양처리24소시(3% O2)。채용소간우RNA(siRNA)파향침묵선감산활화단백격매α1(AMPKα1),채용실시정량취합매련식반응(qRT-PCR)화단백질인적법검측AMPKα1적mRNA화단백수평,병채용매련면역흡부측정(ELISA)검측각조세포백세포개소(IL)-6、IL-1β、종류배사인자-α(TNF-α)분비수평。결과이갑쌍고대결양상태하고혈당유도적염성인자(IL-6、IL-1β、TNF-α)단백분비구유억제작용,병수착농도적증가,억제작용증강。고혈당조IL-6、IL-1β、TNF-α mRNA급단백분비수평고우정상혈당조(P<0.05);고혈당+이갑쌍고조IL-6、IL-1β、TNF-α단백분비수평저우고혈당조(P<0.05);정상혈당조여정상혈당+이갑쌍고조IL-6、IL-1β、TNF-α단백분비수평비교차이무현저성(P>0.05)。이침묵AMPKα1능구상조고혈당+이갑쌍고상태하IL-6、IL-1β、TNF-α단백분비수평,여부전염si-control세포비교차이구유현저성(P<0.05)。결론이갑쌍고능구억제결양상태하고혈당유도소효질세포염성인자적석방,이AMPKα1재기중발휘관건작용。
ObjectiveTo investigate the role of metformin in the hyperglycemia induced proinlfammatory cytokine secretion in N9 microglia under hypoxic condition.MethodN9 cells cultured in vitro were divided into euglycemia group, euglycemia+metformin group, hyperglycemia group and hyperglycemia+metformin group. 2 mmol/L metformin was added into euglycemia+metformin group and hyperglycemia+metformin group for 12 hours. Then, four groups were changed into hypoxia conditions (3% O2) for 24 hours. AMPKα1 siRNA were used to knockout AMPKα1 expression. Quantitative real-time PCR and Western blotting were applied to detect the mRNA and protein level of AMPKα1. ELISA were used to determine secretion levels of IL-6、IL-1β and TNF-α among four groups.ResultMetformin had an inhibitory effect on protein secretion of the inlfammatory cytokines IL-6, IL-1β and TNF-α, and the inhibition effect gradually increased with the increase of metformin dose. As compared with euglycemia group, the protein secretion levels of IL-6, IL-1β and TNF-α signiifcantly increased in hyperglycemia group (P<0.05). As compared with hyperglycemia group, the secretion levels of IL-6, IL-1β and TNF-α signiifcantly decreased in hyperglycemia+metformin group (P<0.05). There were no differences in the protein secretion levels of IL-6, IL-1β and TNF-α between euglycemia group and euglycemia+metformin group (P>0.05). Silencing of AMPKα1 significantly upregulated IL-6, IL-1β and TNF-α secretion levels under hyperglycemia+metformin condition, as compared with the si-control transfected cells.ConclusionMetformin can inhibit hyperglycemia induced proinflammatory cytokine secretion in microglia under hypoxic condition, and AMPKα1 plays a vital role in the metformin induced effect.